Factor XI apple domains and protein dimerization

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 11, 2003, Pages 2340-2347

  Cheng, Q ^a   Sun, M F ^a   Kravtsov, D V ^a   Aktimur, A ^a   Gailani, D ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

Apple domain; Dimer; Factor xi; Prekallikrein

Indexed keywords

BLOOD CLOTTING FACTOR 9; DISULFIDE; HYBRID PROTEIN; PREKALLIKREIN;

ARTICLE; BINDING SITE; CHEMISTRY; DIMERIZATION; GEL CHROMATOGRAPHY; GENETICS; HUMAN; MOLECULAR CLONING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN TERTIARY STRUCTURE;

BINDING SITES; CHROMATOGRAPHY, GEL; CLONING, MOLECULAR; DIMERIZATION; DISULFIDES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FACTOR IX; HUMANS; PREKALLIKREIN; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS;

EID: 3042802820     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00418.x     Document Type: Article

References (30)

1. Fujikawa K, Chung D, Hendrickson L, Davie E. Amino acid sequence of human factor XI, a blood coagulation factor with four tandem repeats that are highly homologous with plasma prekallikrein. Biochemistry 1986; 25: 2417-24.
2. Chung D, Fujikawa K, McMullen B, Davie E. Human plasma pre kallikrein, a zymogen to a serine protease that contains four tandem repeats. Biochemistry 1986; 25: 2410-7.
3. McMullen B, Fujikawa K, Davie E. Location of the disulfide bonds in human coagulation factor XI: the presence of tandem apple domains. Biochemistry 1991; 30: 2056-60.
4. McMullen B, Fujikawa K, Davie E. Location of the disulfide bonds in human plasma prekallikrein: presence of four novel apple domains in the amino-terminal portion of the molecule. Biochemistry 1991; 30: 2050-6.
5. Davie E, Fujikawa K, Kisiel W. The coagulation cascade: initiation, maintenance and regulation. Biochemistry 1991; 30: 10363-70.
6. Colman R, Schmaier A. Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes. Blood 1997; 90: 3819-43.
7. Gailani D, Broze G. Factor XI and the contact system. In: Scriver, C, Beaudet A, Sly W, Valle D, Childs B, Kinzler K Vogelstein B, eds. Metabolic and Molecular Basis of Inherited Disease, 8 edn. New York: McGraw-Hill, 2001: 4433-53.
8. Baglia F, Jameson B, Walsh P. Identification and chemical synthesis of a substrate binding site for factor IX on coagulation factor XIa. J Biol Chem 1991; 266: 24190-7.
9. Baglia F, Walsh P. A binding site for thrombin in the apple 1 domain of factor XL J Biol Chem 1996; 271: 3652-8.
10. Sun Y, Gailani D. Identification of a factor IX binding site on the third apple domain of activated factor XL J Biol Chem 1996; 271: 29023-8.
11. Baglia F, Badellino K, Ho D, Dasari V, Walsh P. A binding site for the kringle II domain of prothrombin in the apple 1 domain of factor XL J Biol Chem 2000; 275: 31954-62.
12. Ho D, Badellino K, Baglia F, Sun M-F, Zhao M, Gailani D, Walsh PN. The role of high molecular weight kininogen and prothrombin as cofactors in the binding of factor XI A3 domain to the platelet surface. J Biol Chem 2000; 275: 25139-45.
13. Renné T, Gailani D, Meijers J, Mülller-Esterl W. Characterization of the H-kininogen-binding site on factor XI: a comparison of factor XI and plasma prekallikrein. J Biol Chem 2002; 277: 4892-9.
14. Renné T, Sugiyama A, Gailani D, Jahnen-Dechent W, Walter U, Mülller-Esterl W Fine mapping of the H-kininogen binding site in plasma prekallikrein apple 2 domain. Int Immunopharmacol 2002; 2: 1867-73.
15. Meijers J, Davie E, Chung D. Expression of human blood coagulation factor XI: characterization of the defect in factor XI type III deficiency. Blood 1992; 79: 1435-40.
16. Gailani D, Ho D, Sun M-F, Cheng Q, Walsh P. Model for a factor IX activating complex on blood platelets: dimeric conformation of factor XIa is essential. Blood 2001; 97: 3117-22.
17. Meijers J, Mulvihill E, Davie E, Chung D. Apple 4 in human blood coagulation factor XI mediates dimer formation. Biochemistry 1992; 31: 4680-4.
18. Sun M-F, Zhao M, Gailani D. Identification of amino acids on the factor XI apple 3 domain required for activation of factor IX. J Biol Chem 1999; 274: 36373-8.
19. Bouma B, Griffin J. Human blood coagulation factor XI, purification, properties, and mechanism of activation by activated factor XII. J Biol Chem 1977; 252: 6432-7.
20. Fujikawa K, Lagaz M, Kato H, Davie E. The mechanism of activation of bovine factor IX (Christmas factor) by bovine factor XIa (activated plasma thromboplastin antecedent). Biochemistry 1974; 13: 4508-16.
21. Mashiko H. Factor XL Purification from porcine plasma by affinity chromatography and some properties of factor XI and activated factor XL Bio Chem Hoppe-Seyler 1994; 375: 481-4.
22. Gailani D, Sun M, Sun Y. A comparison of murine and human factor XL Blood 1997; 90: 1055-64.
23. Sinha D, Marcinkiewicz M, Gailani D, Walsh P. Molecular cloning and biochemical characterization of rabbit factor XL Biochem J 2002; 367: 49-56.
24. Asakai R, Chung D, Davie E, Seligsohn U. Factor XI deficiency in Ashkenazi Jews in Israel. N Eng J Med 1991; 325: 153-8.
25. Asakai R, Chung D, Ratnoff O, Davie E. Factor XI (plasma thrombo plastin antecedent) deficiency in Ashkenazi Jews is a bleeding disorder that can result from three types of point mutations. Proc Natl Acad Sci USA 1989; 86: 7667-71.
26. Peretz H, Mulai A, Usher S, Zivelin A, Segal A, Weisman Z, Mittleman M, Lupo H, Lanir N, Brenner B, Shpilberg O, Seligsohn U. The two common mutations causing factor XI deficiency in Jews stem from distinct founders: one of ancient Middle Eastern origin and another of more recent European Origin. Blood 1997; 90: 2654-9.
27. Baglia F, Walsh P. Thrombin-mediated feedback activation of factor XI on the activated platelet surface is preferred over contact activation by factor Xlla or factor XIa. J Biol Chem 2000; 275: 20514-9.
28. Baglia FA, Badellino KO, Li CQ, Lopez JA, Walsh PN. Factor XI binding to the platelet glycoprotein Ib-IX-V complex pro motes factor XI activation by thrombin. J Biol Chem 2002; 277: 1662-8.
29. Ho D, Baglia F, Walsh P. Factor XI binding to activated platelets is mediated by residues R(250), K(255), F(260), and Q(263) within the apple 3 domain. Biochemistry 2000; 39: 316-23.
30. Dorfman R, Walsh PN. Noncovalent interactions of the Apple 4 domain that mediate coagulation factor XI homodimerization. J Biol Chem 2001; 276: 6429-38.